Delivery Order SPE2DB22D3004-SPE2DB24FQQ79
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,097.08, has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $6,488.12 and an ultimate completion date of May 22, 2024. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The $3,291.24 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on May 28, 2024 with a completion date of May 29, 2024. The contract is a Delivery Order and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The $4,404.16 firm fixed-price contract was awarded on June 6, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is a Delivery Order valued at $2,495.95 for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The award was made by the Defense Logistics Agency (DLA), which is a defense agency, for fulfillment by May 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025, as well as a smaller IDC with the...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The single-award Indefinite Delivery Contract (IDC), valued up to $999,999,999.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen as the prime contractor. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $3,486.62 and an ultimate completion date of April 9, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The award is a Delivery Order with a Firm Fixed Price of $2,171.78, with an ultimate completion date of April 23, 2024. The contracting agency is the Defense Logistics Agency (DLA), which is a defense agency supporting the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a larger Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,531.30 under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, with a completion date of December 19, 2024. This award is part of Amerisourcebergen's broader IDC with the DLA, valued at $999,999,999 and running through...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA). The $3,662.22 firm fixed-price delivery order is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, with a period of performance through May 15, 2025. The award is not designated as a set-aside and represents an open competition contract. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FQQ79Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract, valued at $4,189.94, was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 6, 2024 with a completion date of June 7, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 6/6/24 |